SR 141716, better known as Rimonabant, is an inverse agonist at the type-1 cannabinoid receptor (CBR1), and thus belongs to the first pharmacological category of nootropics
Hsieh, M.-J., Liu, H.-T., Wang, C.-N., Huang, H.-Y., Lin, Y., Ko, Y.-S., Wang, J.-S., Chang, V
However, in human mesenchymal stem cells, GLP-1 inhibited early adipocyte differentiation and instead promoted proliferation of undifferentiated mesenchymal stem cells [77]
Case reports of Melanotan II describe patients developing darkening of pre-existing moles and oral mucosa, priapism requiring emergency intervention, injection-site ulceration and pyoderma gangrenosum , renal infarction , and even a possible association with reports of ischemic strokeafter intranasal use
I will not do that